Medication source: identify whether a product came from a licensed pharmacy or another channel
Under NICE TA875, semaglutide (Wegovy) treatment on the NHS is usually limited to 2 years within specialist weight management services
It is typically administered through a weekly injection and has become a popular option for people seeking weight loss assistance
Because different GLP-1 agonists have different FDA-labeled indications, they may be used for different reasons, such as type 2 diabetes or weight loss
GLP-1 therapy helps reduce appetite, control cravings, and improve portion control, making it easier to develop healthy habits that support long-term success
In contrast, resting serum SPARC level was not modified between pre- and post-training [22]